Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMS-986339 is an orally active, potent FXR agonist that engages His298 and ASN287 residues via H-bond formation. It is employed in research on primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH) due to its anti-fibrosis properties.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.156 € | 10-14 weeks | |
50 mg | 2.831 € | 10-14 weeks | |
100 mg | 3.800 € | 10-14 weeks |
Description | BMS-986339 is an orally active, potent FXR agonist that engages His298 and ASN287 residues via H-bond formation. It is employed in research on primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH) due to its anti-fibrosis properties. |
Molecular Weight | 643.71 |
Formula | C35H41F4N3O4 |
Cas No. | 2477873-64-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.